Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.04.19.590327

A Comparison of Techniques to Determine Active Motor Threshold for Quadriceps Transcranial Magnetic Stimulation Research

Abstract

The determination of active motor threshold (AMT) is a critical step in transcranial magnetic stimulation (TMS) research protocols involving voluntary muscle contractions. As AMT is frequently determined using an absolute electromyographic (EMG) threshold (e.g., 200{micro}V peak-to-peak amplitude), wide variation in EMG recordings across participants has given reason to consider a relative threshold (e.g., = 2x background EMG) for AMT determination. However, these approaches have not been systemically compared. PURPOSE: We sought to compare the AMT estimations derived from absolute and relative criteria commonly used to determine AMT in the quadriceps muscles, and assess the test-retest reliability of each approach (absolute = 200{micro}V vs. relative = 2x background EMG). METHODS: Eighteen young adults (9 males and 9 females; mean {+/-} SD age = 23 {+/-} 2 years) visited the research laboratory on two occasions. All testing was conducted on the dominant limb. During each laboratory visit, maximal voluntary isometric contraction (MVIC) quadriceps torque was measured, with all subsequent TMS procedures conducted as participants maintained 10% of MVIC torque. AMT was derived from each criterion using motor evoked potentials recorded from the vastus lateralis (VL) and defined as the lowest stimulator output (SO%) needed to meet the specified criteria within [≥] 5/10 pulses. The order of criteria (i.e., absolute vs. relative) was randomized during the first laboratory visit, and counterbalanced during the second visit. A paired samples t-test, 95% confidence intervals and the effect size were used to compare mean differences in AMT estimations obtained from each criterion during the second laboratory visit. Paired samples t-tests, intraclass correlation coefficients (ICC2,1), standard errors of measurement (SEMs), and the minimal difference (MD) scores were calculated to assess test-retest reliability of each AMT criterion. RESULTS: Differences between the AMT criteria were small and not statistically significant (absolute criterion mean = 48.9%, relative criterion mean = 47.4%; p = .309, Cohens d = 0.247). The absolute criterion demonstrated moderate to excellent reliability (ICC2,1= .866 [0.648 - 0.950], SEM = 7.9%, MD = 10.4%), but higher AMTs were observed in the second visit compared to the first (p = 0.043). The relative criteria demonstrated good-to-excellent test-retest reliability (ICC2,1= .894 [0.746 - 0.959], SEM = 6.9%, MD = 8.9%) and AMTs were not different between visits (p = 0.420). CONCLUSIONQuantifying AMT with an absolute voltage threshold of 200{micro}V peak-to-peak amplitude and a relative voltage threshold 2x background EMG resulted in similar estimations within a single testing session. However, the relative voltage criterion demonstrated superior test-retest reliability. TMS researchers aiming to track corticospinal characteristics across visits should consider implementing relative criterion approaches during their AMT determination protocol.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Beausejour, J. P., Rusch, J., Knowles, K. S., Pagan, J. I., Chaput, M., Norte, G. E., DeFreitas, J. M., Stock, M. S.. 2024-04-25. A Comparison of Techniques to Determine Active Motor Threshold for Quadriceps Transcranial Magnetic Stimulation Research. https://doi.org/10.1101/2024.04.19.590327

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗